Free Newsletter
UK aims to slice drug prices 10%
A pharma nightmare with an English accent: The UK government wants to slash prices for prescription drugs by 10 percent. Sources told the Financial Times that officials are seeking a $2 billion-plus reduction off the current $21.7 billion annual spending on meds.
On the record, Health Minister Alan Johnson said he's aiming for "substantial savings" in the National Health Services' drug budget by the time a new agreement with drug companies is finalized in June. The drug-budget cuts would be part of an overall cost-reduction plan for the ministry, which has been directed to cut its spending by 3 percent per year.
Drug makers, of course, are none too cheerful about the prospect. The new cuts would come on top of a 7 percent discount in prices that went into effect in 2005, under a pricing deal that was supposed to be valid through 2010. The Financial Times says that pharma may endorse the idea of taking "branded generics"--or brand-name drugs already off patent--out of the pricing scheme. But that concession would have to be matched by the government, namely higher prices for new drugs and quicker adoption of new-to-market products.
- read the report in the Financial Times
Related Articles:
UK accepts J&J's money-back guarantee. Report
NHS fights expensive Alzheimer's drugs. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: